Tirzepatide

Tirzepatide is a dual GLP-1 and GIP receptor agonist studied in clinical research for its metabolic effects. Research has examined its potential to modulate blood glucose, enhance insulin secretion, inhibit glucagon release, and improve insulin sensitivity. Studies indicate it may outperform single GLP-1 agonists in HbA1c reduction and weight loss, with additional effects on blood pressure, lipid metabolism, and adiponectin levels.